IMVT
IMVT
NASDAQ · Biotechnology

Immunovant Inc

$24.76
+0.92 (+3.86%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 18 78%
Hold 5 22%
Sell 0 0%
Price Target
Analyst Price Target +146.1% upside
Low Target $43.15
Average Target $60.94
High Target $94.48
Current Price $24.76
Current
$24.76
Target
$60.94
$43.15 $60.94 avg $94.48
Scenario Analysis
Bear Case
$43.15
74.3%
Low target
Base Case
$60.94
+146.1%
Avg target
Bull Case
$94.48
+281.6%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$27.92
-11.3% from high
52-Week Low
$12.72
+94.7% from low
50-Day SMA
$25.99
-4.7% vs SMA
200-Day SMA
$19.59
+26.4% vs SMA
RSI (14)
49.5
Neutral
Target vs 52W High
$60.94
+118.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%